Skip to Main Content

Advertisement

Skip Nav Destination

The Clinicopathologic and Prognostic Value of Hypoxia-Inducible Factor-2α in Cancer Patients: A Systematic Review and Meta-Analysis

Cancer Epidemiol Biomarkers Prev (2019) 28 (5): 857–866.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Matthew D. Bailey
  • Guo‐Xia Jin
  • Fabio Carniato
  • Mauro Botta
  • Matthew J. Allen
Chemistry – A European Journal (2021) 27 (9): 3114.
  • Yan Fu
  • Tiantian Zou
  • Xiaotian Shen
  • Peter J. Nelson
  • Jiahui Li
  • Chao Wu
  • Jimeng Yang
  • Yan Zheng
  • Christiane Bruns
  • Yue Zhao
  • Lunxiu Qin
  • Qiongzhu Dong
MedComm (2021) 2 (1): 27.
  • Kui Zang
  • Liangliang Hui
  • Min Wang
  • Ying Huang
  • Xingxing Zhu
  • Bin Yao
Frontiers in Oncology (2021) 11
  • Carolina Méndez-Blanco
  • Paula Fernández-Palanca
  • Flavia Fondevila
  • Javier González-Gallego
  • José L. Mauriz
Therapeutic Advances in Medical Oncology (2021) 13: 175883592098707.
  • Maryam Nakhjavani
  • Eric Smith
  • Kenny Yeo
  • Helen M. Palethorpe
  • Yoko Tomita
  • Tim J. Price
  • Amanda R. Townsend
  • Jennifer E. Hardingham
Cancers (2021) 13 (9): 2223.
  • Ross King
  • Conall Hayes
  • Claire L Donohoe
  • Margaret R Dunne
  • Maria Davern
  • Noel E Donlon
World Journal of Gastrointestinal Oncology (2021) 13 (5): 312.
  • Ellen C. de Heer
  • Mathilde Jalving
  • Adrian L. Harris
Journal of Clinical Investigation (2020) 130 (10): 5074.
  • Yizhi Wang
  • Xi Zhong
  • Li Zhou
  • Jun Lu
  • Bolun Jiang
  • Chengxi Liu
  • Junchao Guo
Frontiers in Oncology (2020) 10
  • É. Cohen-Jonathan-Moyal
  • V. Vendrely
  • L. Motte
  • J. Balosso
  • J. Thariat
Cancer/Radiothérapie (2020) 24 (6-7): 699.
  • Pramod Mallikarjuna
  • Raviprakash T. Sitaram
  • Karthik Aripaka
  • Börje Ljungberg
  • Marene Landström
Cell Cycle (2019) 18 (17): 2141.
  • Andrew Redfern
  • Veenoo Agarwal
  • Erik W. Thompson
Current Opinion in Clinical Nutrition & Metabolic Care (2019) 22 (4): 250.
Close Modal

or Create an Account

Close Modal
Close Modal